From the Perinatal Research Centre, Departments of Obstetrics/Gynaecology
and Physiology, University of Alberta, Edmonton, Alberta, Canada (S.T.D.); and
Magee-Womens Research Institute, Departments of Obstetrics, Gynecology &
Reproductive Sciences, University of Pittsburgh (Pa) (J.O., M.K.M.).
Correspondence to Sandra T. Davidge, 220 Heritage Medical Research Centre, University of Alberta, Edmonton, Alberta, Canada T6G 2S2. E-mail sandra.davidge{at}ualberta.ca
The pathophysiology of many vascular diseases include
endothelial cell dysfunction.7 8
The endothelium, which lines the lumen of all blood
vessels, has many functions including the maintenance of
vascular integrity, regulation of intravascular coagulation, and
modification of contractile responses of the underlying smooth muscle.
The modulation of vascular smooth muscle tone is regulated, in part,
through release of endothelium-derived vasoactive
agents such as NO.
Endothelial cells are constantly being subjected to
oxidative stress and are therefore a primary target of oxygen-derived
free radicalmediated mechanisms. Alterations in
endogenous free radical production under conditions
of oxidative stress may play an important role in modulating
spontaneous and agonist-stimulated NO production and thus alter
vascular function. Superoxide anion is an oxygen-derived free radical
that is known to interact with NO and reduce its ability to act as a
vasodilator.9 10 Furthermore, the interaction of
superoxide anions with NO results in the production of the cell
damaging prooxidant peroxynitrite.10
We tested the hypothesis that lowering antioxidant protection
through dietary vitamin E deficiency would alter vascular function
through the interaction of superoxide anions and NO.
Assessment of Oxidative State
Lipid peroxidation is an important manifestation of oxidative stress
that occurs when oxygen free radicals interact with polyunsaturated
fatty acids in membranes or lipoproteins. We assayed for evidence of
lipid peroxidation to determine if our model of vitamin E
deprivation resulted in oxidative stress. Malondialdehyde,
a product of lipid peroxides detectable in serum, was used as an
indicator of lipid peroxidation. Malondialdehyde concentrations were
determined by high-pressure liquid chromatography by
use of the technique of Wong et al.14 The
detection limit of this assay is 0.15 µmol of malondialdehyde
per liter of serum. All samples were analyzed in one run of the
assay to avoid interassay variation.
Vessel Preparation
Resting Length-Tension Curve
Solutions and Drugs
Experimental Design
The studies performed involving the absence and presence of
inhibitors were conducted sequentially on the same artery.
The reproducibility of repeating curves for these experiments was
determined in a preliminary set of experiments designed to test for
tachyphylaxis.
Western Blot
After separation, samples were transferred to a membrane (Nylon NT,
Magnagraph, Inc). Prestained standards (high and low molecular weight,
BioRad) were included in separate lanes in each gel for identification
of the approximate molecular weight of unknowns. Primary antibody
(nitrotyrosine) was incubated for 2 hours; secondary antibody (horse
radish peroxidase conjugated) was incubated for 1 hour, and ECL
detection (Amersham LIFE Science) was used.
Autoradiography was done with the use of scientific
imaging film (X-OMAT AR, Kodak).
Data Analysis
Vascular Responses
To determine whether SOD relaxation was dependent on NO, SOD was
repeated in the presence of the NO synthase inhibitor
L-NMMA. L-NMMA effectively blocked relaxation of SOD for both the
arteries from control and vitamin Edeprived rats (Fig 3
Because the SOD response appeared to be NO dependent, we next tested
whether increasing substrate availability for NO would result in a
differential response in arteries of control and vitamin Edeprived
rats (Fig 4
There was a 100% relaxation response to methacholine in arteries from
both the control and the vitamin Edeprived rats. Fig 5
Western Blot
We observed that vitamin E deprivation resulted in greater
basal NO production that was not available as a vasorelaxant
because of superoxide anions. In contrast, however, relaxation
responses to agonist-induced release of NO was not altered by SOD for
either group of animals. It is evident that the balance between NO and
superoxide anions is critical. From our study, an increased NO release
overcame the inactivation by superoxide anions. The reactions and
reaction rates of NO are complex and are not completely understood. One
aspect of NO is that the half-life is not a constant value and is
inversely proportional to the concentration of NO, so that the
half-life becomes shorter as NO becomes more
concentrated.10 Perhaps under the conditions of
our experiments, the rate of superoxide production was too slow
to consume the amount of NO produced under agonist-stimulated release
and thus did not affect the ability of NO to produce a vasorelaxation
response.
In our study, we used an animal model of vitamin E
deprivation to determine the effect on vascular function,
with specific interest in the interaction of superoxide anion and NO.
Vitamin E is a mixture of compounds called tocopherols, the
most potent of which is
Superoxide anion is an oxygen-derived free radical formed by univalent
reduction of molecular oxygen. By dismutation with SOD, superoxide
anions are reduced to hydrogen peroxide. Hydrogen peroxide may be
further reduced to molecular oxygen and water by catalase. Superoxide
anions may participate in the regulation of vascular tone in normal
physiological conditions as well as vascular
pathologies. In an animal model of hypertension,
intravenous injection of SOD reduced blood pressure in
spontaneously hypertensive rats but not in Wistar-Kyoto normotensive
rats.18 Similar to our study, in the diabetic rat
aorta, SOD produced a greater relaxation in diabetic aorta compared
with control. The authors suggested that a greater release of
spontaneous NO is masked by inactivation of NO by
superoxide.19 Similar to the diabetic aorta, the
addition of catalase did not alter vascular reactivity for mesenteric
arteries from vitamin Edeprived rats, indicating that hydrogen
peroxide was not contributing to the vascular response under these
conditions. In contrast, Rubanyi and Vanhoutte20
demonstrated that hydrogen peroxide was vasoactive by causing a
relaxation response in canine coronary arteries.
In our study, it appears that superoxide anions were responsible for
inactivation of NO. This interaction of superoxide anions with NO could
lead to an increase in peroxynitrite formation.10
Peroxynitrite is a stable and powerful prooxidant that is cytotoxic
through direct oxidative mechanisms.10 In
addition, peroxynitrite decomposition yields the hydroxyl radical,
which is also a powerful oxidant that has important pathological
actions on the vasculature.21
Another aspect of peroxynitrite is that it may interfere with
pathways important to vascular function, such as modulating
prostaglandin production. Landino et
al22 demonstrated that peroxynitrite can
activate prostaglandin endoperoxide
synthase (PGHS), leading to increased eicosanoid synthesis. In a
previous study, we observed an increased NO response along with an
increased PGHS-dependent vasoconstrictor in arteries from vitamin
Edeprived rats.23 More recently, we and others
have demonstrated that NO can modulate prostaglandin
synthesis in cells and tissue.24 25 26 27 28 Tsai et
al29 reported that NO is not capable of
stimulating isolated PGHS, which suggests that an intermediate pathway
for NO may exist. Indeed, the study of Landino et
al22 establishes that superoxide anion could
serve as a link between NO and prostaglandin synthesis. In
the vitamin Edeprived rat model, we have demonstrated an increase NO
production that is inactivated by superoxide
anions; perhaps the resulting product, peroxynitrite, is
responsible for the previously observed increase in PGHS-dependent
vasoconstriction.
Although peroxynitrite may have an active role in the vascular
response in the vitamin Edeficient rat model, we were not able to
demonstrate through immunoblotting evidence for
increased peroxynitrite formation. Nitrotyrosine was used as a marker
for peroxynitrite oxidation of proteins.30
Tyrosine nitration is not necessarily due to the formation of
peroxynitrite, although peroxynitrite is thought to be the principle
source.10 This method and antibody have been used
to demonstrate that extensive nitration takes place around foamy
macrophages in human atherosclerotic
lesions.30 In our study, nitrotyrosine residues
were present in arteries from both the vitamin Edeprived rats and
control rats, but the amount of nitrotyrosine observed was not
different between the two groups. In the vitamin Edeprived rat model,
the role of peroxynitrite in vascular pathophysiology may be more
subtle than that observed with atherosclerotic lesions and therefore
may not be detected through immunostaining.
Alternatively, although the interaction of NO and superoxide
anions is well documented, there is a possibility that superoxide
anions inhibited the release and/or formation of NO. The lack of
nitrotyrosine formation in the arteries of the vitamin
Edeficient animals may support this mechanism.
In summary, our data indicate that arteries from the vitamin
Edeprived rats, compared with control rats, release more spontaneous
NO that is inhibited by superoxide anions. We speculate that in
conditions of oxidative stress (lower vitamin E levels), altered
vascular function may be due to increased destruction of NO by
oxygen-derived free radicals.
Received August 1, 1997;
first decision September 11, 1997;
accepted November 5, 1997.
2.
Halliwell B, Gutteridge JMC. The importance of free
radicals and catalytic metal ions in human diseases. Mol Aspects
Med. 1985;8:89193.[Medline]
[Order article via Infotrieve]
3.
Hennig B, Chow CK. Lipid peroxidation and
endothelial cell injury: implications in
atherosclerosis. Free Radic Biol Med. 1988;4:99106.[Medline]
[Order article via Infotrieve]
4.
Hubel CA, Roberts JM, Taylor RN, Musci TJ, Rogers GM,
McLaughlin MK. Lipid peroxidation in pregnancy: new perspectives on
preeclampsia. Am J Obstet Gynecol. 1989;161:10251034.[Medline]
[Order article via Infotrieve]
5.
Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E,
Colditz GA, Willett WC. Vitamin E consumption and the risk of
coronary heart disease in men. N Engl J
Med. 1993;328:14501456.
6.
Stampfer MJ, Hennekens CH, Manson JE, Colditz GA,
Rosner B, Willett WC. Vitamin E consumption and the risk of
coronary disease in women. N Engl J Med. 1993;328:14441449.
7.
Vane JR, Anggard EE, Botting RM. Regulatory functions
of the vascular endothelium. N Engl J
Med. 1990;323:2736.[Medline]
[Order article via Infotrieve]
8.
Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA,
McLaughlin MK. Preeclampsia: an endothelial cell
disorder. Am J Obstet Gynecol. 1989;161:12001204.[Medline]
[Order article via Infotrieve]
9.
Katusic ZS. Superoxide anion and
endothelial regulation of arterial tone.
Free Radic Biol Med. 1996;20:443448.[Medline]
[Order article via Infotrieve]
10.
Beckman JS, Koppenol WH. Nitric oxide, superoxide and
peroxynitrite: the good, the bad, and the ugly. Am J
Physiol. 1996;271(5 Pt I): C1424C1437.
11.
Bieri JG. Kinetics of tissue a-tocopherol
depletion and repletion. Ann N Y Acad Sci. 1972;203:181191.[Medline]
[Order article via Infotrieve]
12.
Bieri JG, Tolliver TJ, Catignani GL.
Simultaneous determination of alpha-tocopherol
and retinal in plasma or red cells by high pressure liquid
chromatography. Am J Clin Nutr. 1972;32:21432151.
13.
Chow FI, Omaye ST. Use of antioxidants in the
analyses of vitamins A and E in mammalian plasma by high
pressure liquid chromatography. Lipids. 1983;18:837842.[Medline]
[Order article via Infotrieve]
14.
Wong SHY, Knight JA, Hopfer SM, Zaharia O, Leach CN,
Sunderman FW. Lipoperoxides in plasma as measured by
liquid-chromatographic separation of
malondialdehyde-thiobarbituric acid adduct. Clin Chem. 1987;33:214220.
15.
Laemmli U. Cleavage of structural proteins during the
assembly of the head of bacteriophage T4. Nature. 1970;277:680685.
16.
Hill A. The combination of hemoglobin with oxygen and
carbon monoxide. Biochem J. 1913;7:471480.
17.
Serbinova EA, Packer L. Antioxidant properties of
18.
Nakazono K, Watanabe N, Matsuno K, Sasaki J, Sato T,
Inoue M. Does superoxide underlie the pathogenesis of hypertension?
Proc Natl Acad Sci U S A.. 1991;88:1004510048.
19.
Langenstroer P, Pieper GM. Regulation of
spontaneous EDRF release in diabetic rat aorta by oxygen free radicals.
Am J Physiol. 1992;263:H257H265.
20.
Rubanyi GM, Vanhoutte PM. Oxygen-derived free radicals,
endothelium, and responsiveness of vascular smooth
muscle. Am J Physiol. 1986;250:H815H821.
21.
Pfeiffer S, Gorren ACF, Schmidt K, Werner ER, Hansert
B, Bohle DS, Mayer B. Metabolic fate of peroxynitrite in
aqueous solution. J Biol Chem. 1997;272:34653470.
22.
Landino LM, Crews BC, Timmons MD, Morrow JD, Marnett
LJ. Peroxynitrite, the coupling product of nitric oxide and
superoxide, activates prostaglandin biosynthesis.
Proc Natl Acad Sci U S A.. 1996;93:1506915074.
23.
Davidge ST, Hubel CA, McLaughlin MK.
Cyclooxygenase-dependent vasoconstrictor alters
vascular function in the vitamin E-deprived rat. Circ Res. 1993;73:7088.
24.
Davidge ST, Baker PN, McLaughlin MK, Roberts JM. Nitric
oxide produced by endothelial cells increases
production of eicosanoids through activation of
prostaglandin H synthase. Circ Res. 1995;77:274283.
25.
Franchi AM, Chaud M, Rettori V, Suburo A, McCann SM,
Gimeno M. Role of nitric oxide in eicosanoid synthesis and uterine
motility in estrogen-treated rat uteri. Proc Natl Acad Sci
U S A. 1994;91:539543.
26.
Rettori V, Gimeno M, Lyson K, McCann S. M. Nitric
oxide mediates norepinephrine-induced
prostaglandin E2 release from the
hypothalamus. Proc Natl Acad Sci U S A. 1992;89:1154311546.
27.
Salvemini D, Misko TP, Masferrer JL, Seibert K, Currie
MG, Needleman P. Nitric oxide activates
cyclooxygenase enzymes. Proc Natl Acad Sci
U S A. 1993;90:72407244.
28.
Swierkosz TA, Mitchell JA, Warner TD, Botting RM, Vane
JR. Co-induction of nitric oxide synthase and
cyclo-oxygenase: interactions between nitric oxide and
prostanoids. Br J Pharmacol. 1995;114:13351342.[Medline]
[Order article via Infotrieve]
29.
Tsai A-L, Wei C, Kulmacz R. Interaction between nitric
oxide and prostaglandin H synthase. Arch Biochem
Biophys. 1994;313:367372.[Medline]
[Order article via Infotrieve]
30.
Beckman JS, Ye YZ, Anderson P, Chen J, Accavetti MA,
Tarpey MM, White CR. Extensive nitration of protein tyrosines observed
in human atherosclerosis detected by
immunohistochemistry. Biol Chem Hoppe-Seyler. 1994;375:8188.[Medline]
[Order article via Infotrieve]
© 1998 American Heart Association, Inc.
Scientific Contributions
Vascular Function in the Vitamin EDeprived Rat
An Interaction Between Nitric Oxide and Superoxide Anions
![]()
Abstract
Top
Abstract
Introduction
Methods
Results
Discussion
References
AbstractWe tested the hypothesis
that oxidative stress, mediated by dietary vitamin E
deprivation, would alter vascular function through the
interaction of oxygen-derived free radicals and nitric oxide (NO). This
interaction may play an important role in the vascular pathophysiology
of many diseases associated with oxidative stress. Mesenteric arteries
from control (n=12) and vitamin Edeprived (n=12) Sprague-Dawley rats
were studied with a myograph. Superoxide dismutase, which scavenges
superoxide anions, produced a significantly greater relaxation in the
arteries from the vitamin Edeprived rats compared with the controls
(P<.05). Superoxide dismutase and catalase produced
results similar to superoxide dismutase alone. Pretreatment with an NO
synthase inhibitor eliminated the superoxide
dismutaseinduced relaxation in arteries from both control and vitamin
Edeprived rats. L-Arginine induced a greater relaxation
in arteries of the vitamin Edeprived group (P<.05).
Agonist-induced relaxation with methacholine was not altered by
superoxide dismutase for either group of animals, indicating that
stimulated release of NO was not influenced by superoxide anions. With
the use of Western immunoblot analysis,
nitrotyrosine residues were shown to be present in arteries from
both the vitamin Edeprived and control rats, but the amount of
nitrotyrosine observed was not different between the two groups. In
summary, our data indicate that there is a greater inhibition of NO
caused by superoxide anions in the vitamin Edeprived group. We
speculate that in conditions of oxidative stress (reduced vitamin E
levels), altered vascular function may be due to increased destruction
of NO by oxygen-derived free radicals.
Key Words: endothelium vitamin E nitric oxide superoxide peroxynitrite superoxide dismutase
![]()
Introduction
Top
Abstract
Introduction
Methods
Results
Discussion
References
Oxidative stress,
defined as an imbalance between prooxidant and antioxidant forces, has
been proposed to be a pathophysiological feature of
many vascular diseases, such as hypertension,1 2
atherosclerosis,3 and the
pregnancy disorder preeclampsia.4 Furthermore,
several epidemiological investigations have provided correlative
evidence for lower levels of the antioxidant vitamin E and risk for
cardiovascular disease.5 6
Although lowered antioxidant protection by vitamin E may have a role in
vascular disease, little is known regarding the consequence of vitamin
E deprivation on vascular function.
![]()
Methods
Top
Abstract
Introduction
Methods
Results
Discussion
References
General Animal Model
Ten-week-old female Sprague-Dawley rats were obtained from
Harlan (Harlan, Ind) and divided into two groups. One group (n=9)
received a diet deficient in vitamin E; the other (n=9) received an
equivalent diet supplemented with 50 IU
DL-
-tocopherol acetate (US Biochemical
Corp)/kg diet. The animals were maintained on these diets for 10 weeks
to adequately deplete plasma and tissue stores of
-tocopherol in the rats receiving the diet deficient in
vitamin E.11 The rats were housed in the
facilities at Magee-Womens Research Institute, which is accredited by
the American Association for the Accreditation of Laboratory Animal
Care.
Rats were killed while under light anesthesia with
methohexital sodium (50 mg/kg body wt), and blood was collected by
heart puncture. Samples were kept at 4°C until
centrifugation, and sera were then stored frozen at
-70°C until assayed. Serum vitamin E levels were analyzed by
high-pressure liquid chromatography according to Bieri
et al12 as modified by Chow and
Omaye.13 The assay modification used the presence
of the antioxidant butylated hydroxytoluene (0.024%) during the
extraction with heptane. All samples were analyzed in one run
of the assay to avoid interassay variation.
A section of the mesentery 5 to 10 cm distal to the pylorus was
rapidly removed and placed in ice-cold HEPES-buffered PSS (HEPES-PSS).
One mesenteric artery averaging 250 µm in diameter was dissected
free from surrounding adipose tissue, cut into two 1.8-mm lengths, and
threaded onto 20-µm wires. These wires were fastened to two stainless
steel blocks that were mounted in an isometric myograph system. One
block was attached to a Kulite strain gauge force transducer (Kulite
Semiconductor Products), the other connected to a displacement
device. The blocks rested in 5-mL glass-jacketed organ baths with
HEPES-PSS solution kept at 37°C. Each experiment had two baths
running simultaneously.
After the arteries were mounted, they were stretched to
0.2
mN/mm vessel length (1 mN=102 mg) and allowed to equilibrate for 1 hour
in HEPES-PSS buffer. The arteries were then given a conditioning
stretch of
0.6 mN. A resting length-tension curve was generated for
each vessel. The arterial circumference that was used to
perform the dose-response curves was obtained by use of the Law of
LaPlace. With this equation, L100 is calculated
from the exponential curve fit of tension versus circumference.
L100 is defined as the circumference the vessel
would have at a transmural pressure of 100 mm Hg. We have found
from our previous studies that dose-response curves obtained at .8
L100 is a point that provides maximum active
force generation with minimum passive tension.
The HEPES-PSS solution used in these experiments contained
(in mmol/L): sodium chloride 142; potassium chloride 4.7;
magnesium sulfate 1.17; calcium chloride 1.56; potassium phosphate
1.18; HEPES 10; and glucose 5.5. The HEPES-PSS solution was maintained
at a pH of 7.4. Stock solutions of phenylephrine
(L-phenylephrine hydrochloride), methacholine
(acetyl-ß-methylcholine chloride) (all from Sigma), and meclofenamate
(Warner Lambert) were prepared in HEPES-PSS at a concentration of
10 mmol/L for each experiment. A stock solution of 10 mmol/L
of L-NMMA (Cayman Chemical Co) was prepared in water. Stock solutions
of SOD (2000 U/mL) and catalase (50 000 U/mL) were prepared in
HEPES-PSS. Appropriate dilutions of all stocks were obtained with the
use of HEPES-PSS.
Two separate baths were used to study arterial
segments simultaneously. Cumulative doses of
phenylephrine (0.3 to 10 µmol/L) were administered
to determine the dose that would give a 50% contraction for each
individual artery. The EC50 of
phenylephrine was used to constrict arteries to achieve a
baseline from which subsequent relaxation responses were measured.
After completion of each dose-response curve, a 30-minute recovery
period was allowed, during which the baths were changed every 10
minutes with fresh HEPES-PSS. To determine whether superoxide anions
modulated vascular function, SOD was used to reduce superoxide anions
to hydrogen peroxide. In the presence of catalase, hydrogen peroxide is
further reduced to water and molecular oxygen. Therefore, cumulative
doses of SOD (1 to 10 U/mL) in the absence or presence of catalase (500
U/mL) were conducted. The curves were generated in the absence or
presence of the NO synthase inhibitor L-NMMA (100
µmol/L) to determine a role for NO in the responses. Cumulative doses
of the muscarinic agonist methacholine (0.01 to 1 µmol/L) in the
absence or presence of SOD (50 U/mL) were administered to assess the
potential role of superoxide anions on
endothelial-dependent (NO-dependent) relaxation
responses. The response of mesenteric arteries to an exogenous source
of L-arginine or D-arginine (0.01 to 100
µmol/L) was also determined.
Evidence of peroxynitrite formation in mesenteric arteries from
control and vitamin Edeficient animals was evaluated indirectly by
the presence of nitrotyrosine residues. Western immunoblot
for nitrotyrosine residues was conducted with a monoclonal
antinitrotyrosine antibody (Upstate Biotechnology Inc). A standard of
nitrosylated proteins was prepared, using a heart perfused with
200 µmol/L of peroxynitrite. Mesenteric arteries were
homogenized in Tris-Cl buffer containing protease
inhibitors. For gel electrophoresis, samples were diluted
by addition of an equal volume of 2x gel sample buffer (40 mmol/L
Tris/Cl, pH 6.8, 2% SDS, 10% 2-mercaptoethanol, 20% glycerol, and
0.02% bromphenol blue). Samples were boiled for 5 minutes and
centrifuged at 10 000g for 2 minutes. Aliquots of
10 µL were loaded into individual wells formed within the stacking
gel (5% acrylamide in stacking gel buffer, 25 mmol/L
Tris-HCl, pH 6.8) overlaid on 12% acrylamide gels in
Tris-HCl, pH 8.8, and separated by electrophoresis at 100 to 300 V for
1 hour in a minigel apparatus according to the method
of Laemmli.15
The Student's two-tailed t test was used to
determine the statistical difference of the parameters
between the control and vitamin Edeprived rats shown in the
Table
. Maximum response to superoxide dismutase and
L-arginine was also evaluated with the Student's
two-tailed t test. The data from the methacholine
dose-response curve was fitted to the Hill
equation,16 from which a straight line was
generated by linear least-squares regression analysis. The mean
effective concentration that produced a 50% response
(EC50) was determined from this line and
expressed as the geometric mean±SEM. A two-way ANOVA with repeated
measures was used to compare the response to a drug before and after
SOD. Pairwise comparison was then conducted using the
Student-Newman-Keuls test. Differences among means were considered
significant at a value of P<.05.
View this table:
[in a new window]
Table 1. Animal Model: Control and Vitamin EDeprived Rats
![]()
Results
Top
Abstract
Introduction
Methods
Results
Discussion
References
Animal Model
The Table
depicts the results for the assessment of the
peroxidative state in the rats. There was no difference in body weights
between the vitamin Edeprived and control rats, indicating that
growth was not impaired by vitamin E deprivation. As
expected, vitamin E levels were significantly less in the vitamin
Edeprived group than in the controls. Serum malondialdehyde
concentrations were elevated in the vitamin Edeprived rats.
Mesenteric arteries preconstricted with their
EC50 of phenylephrine demonstrated a
concentration-dependent relaxation response to SOD that was greater in
the arteries from the vitamin Edeprived rats than in arteries of the
control rats (Fig 1
). To determine
whether hydrogen peroxide produced in the presence of SOD was
responsible for the enhanced relaxation, the SOD dose-response curve
was repeated in the presence of catalase. Catalase did not
significantly affect the relaxation to SOD for either groups of animals
(Fig 2
).

View larger version (15K):
[in a new window]
Figure 1. Concentration-response curves to SOD for
mesenteric arteries from control (n=9,
) and vitamin Edeprived
(n=9,
) rats. Responses are expressed as a percentage of relaxation
from phenylephrine-preconstricted levels. Data
represent mean±SEM. *Significant (P<.01)
difference between control and vitamin Edeprived rats.

View larger version (17K):
[in a new window]
Figure 2. Concentration-response curves to SOD in the
absence (solid lines) or presence (dashed lines) of catalase for
mesenteric arteries from control (n=9,
) and vitamin Edeprived
(n=9,
) rats. Responses are expressed as a percentage of relaxation
from phenylephrine-preconstricted levels. Data
represent mean±SEM.
).

View larger version (16K):
[in a new window]
Figure 3. Concentration-response curves to SOD in the
absence (solid lines) or presence (dashed lines) of L-NMMA (an NO
synthase inhibitor) for mesenteric arteries from control
(n=9,
) and vitamin Edeprived (n=9,
) rats. Responses are
expressed as a percentage of relaxation from
phenylephrine-preconstricted levels. Data represent
mean±SEM.
). L-Arginine
relaxed arteries from the vitamin Edeprived rats to a greater extent
than the arteries of the control animals. D-Arginine had no
effect on vascular reactivity for either group of animals (data not
shown).

View larger version (13K):
[in a new window]
Figure 4. Concentration-response curves to
L-arginine in mesenteric arteries from control (n=9,
)
and vitamin Edeprived (n=9,
) rats. Responses are expressed as a
percentage of relaxation from phenylephrine-preconstricted
levels. Data represent mean±SEM. *Significant
(P<.01) difference between control and vitamin
Edeprived rats.
depicts the EC50
values for this relaxation response to methacholine alone and
methacholine in the presence of SOD for arteries from both groups of
rats. Methacholine produced a similar relaxation response in arteries
from both the control and vitamin Edeprived rats
(EC50=0.075±0.009 versus 0.077±0.006
µmol/L). Pretreatment with SOD did not alter the relaxation for
arteries in either the control or the vitamin Edeprived groups. The
majority of the relaxation response to methacholine was NO dependent.
The NO synthase inhibitor L-NMMA effectively
inhibited the relaxation response to methacholine, with the exception
of the highest dose of methacholine (1 µmol/L).

View larger version (22K):
[in a new window]
Figure 5. EC50 values for methacholine alone
(n=9, open bars) and methacholine in the presence of SOD (n=9, hatched
bars) in mesenteric arteries from control and vitamin Edeprived rats.
Bars represent mean±SEM.
A representative immunoblot for
nitrotyrosine residues in mesenteric arteries from control and vitamin
Edeprived rats is shown in Fig 6
.
Nitrotyrosine residues were present in arteries from both the
control and the vitamin Edeficient animals. There was no difference
in the intensity of immunostaining between the two
groups (in arbitrary units; control=89.7±5.8, vitamin
Edeprived=67.4±14.6).

View larger version (28K):
[in a new window]
Figure 6. Representative Western
immunoblot for nitrotyrosine, a marker of peroxynitrite
formation. Lane 1 is a standard of nitrosylated proteins from a heart
perfused with 200 µmol/L peroxynitrite; lanes 2, 3, and 4 are
mesenteric arteries from control rats; lanes 5, 6, and 7 are mesenteric
arteries from vitamin Edeprived rats.
![]()
Discussion
Top
Abstract
Introduction
Methods
Results
Discussion
References
The purpose of this study was to investigate whether
oxidative stress, mediated by a dietary vitamin E deficiency, would
alter vascular function through an interaction of oxygen-derived free
radicals and NO. We proposed that the reaction of superoxide anion with
NO would reduce the availability of NO as a vasorelaxant and also
result in the production of peroxynitrite, a potential
cytotoxic oxidant. Our study demonstrated that arteries from the
vitamin Edeprived rats relaxed to a greater extent to SOD compared
with the control rats. The presence of catalase did not alter the
relaxation response to SOD, indicating that the response was not due to
hydrogen peroxide. Pretreatment of arteries with an NO synthase
inhibitor eliminated the SOD-induced relaxation response in
arteries from both the control and vitamin Edeprived rats. These data
indicate that there is a greater inhibition of NO because of superoxide
anions in the vitamin Edeprived group.
-tocopherol.17 Low levels of
vitamin E are related to a higher occurrence of
cardiovascular disease, and intake of vitamin E lowers
the risk of coronary heart disease.5 6
Vitamin E is well known as a lipid-soluble antioxidant that scavenges
lipid peroxyl radicals within cellular membranes. Because of a hydroxyl
group that is exposed to the aqueous phase, vitamin E has the capacity
to scavenge oxygen radicals attacking from outside the
membrane.17
![]()
Selected Abbreviations and Acronyms
L-NMMA
=
NG-monomethyl-L-arginine
NO
=
nitric oxide
PSS
=
physiological saline solution
SOD
=
superoxide dismutase
![]()
Acknowledgments
Dr S.T. Davidge is supported by the Medical Research Council of
Canada, the Heart and Stroke Foundation of Canada, and the Alberta
Heritage Foundation for Medical Research. Dr M.K. McLaughlin is
supported by National Institutes of Health grant HD30367. We thank
Karen Schuler and Wahida Yasmin for their excellent technical
assistance.
![]()
References
Top
Abstract
Introduction
Methods
Results
Discussion
References
1.
Rubanyi GM. Vascular effects of oxygen-derived
free radicals. Free Radic Biol Med. 1988;4:107120.[Medline]
[Order article via Infotrieve]
-tocopherol and
-tocotrienol. Methods
Enzymol. 1994;234:354366.[Medline]
[Order article via Infotrieve]
This article has been cited by other articles:
![]() |
S. J. Williams, D. G. Hemmings, J. M. Mitchell, I. C. McMillen, and S. T. Davidge Effects of maternal hypoxia or nutrient restriction during pregnancy on endothelial function in adult male rat offspring J. Physiol., May 15, 2005; 565(1): 125 - 135. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. V. Turko and F. Murad Protein Nitration in Cardiovascular Diseases Pharmacol. Rev., December 1, 2002; 54(4): 619 - 634. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. STULAK, A. LERMAN, M. R. PORCEL, J. A. CACCITOLO, J. C. ROMERO, H. V. SCHAFF, C. NAPOLI, and L. O. LERMAN Renal Vascular Function in Hypercholesterolemia Is Preserved by Chronic Antioxidant Supplementation J. Am. Soc. Nephrol., September 1, 2001; 12(9): 1882 - 1891. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.W. Laight, M.J. Carrier, and E.E. Anggard Antioxidants, diabetes and endothelial dysfunction Cardiovasc Res, August 18, 2000; 47(3): 457 - 464. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Varin, P. Mulder, F. Tamion, V. Richard, J.-P. Henry, F. Lallemand, G. Lerebours, and C. Thuillez Improvement of Endothelial Function by Chronic Angiotensin-Converting Enzyme Inhibition in Heart Failure : Role of Nitric Oxide, Prostanoids, Oxidant Stress, and Bradykinin Circulation, July 18, 2000; 102(3): 351 - 356. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |